Respiratory Syncytial Virus (RSV) Research Study
Respiratory Syncytial Virus (RSV) is an easily transmittable virus that affects the lungs and airways, with symptoms similar to the flu or COVID-19.
Accellacare is enrolling volunteers into a study evaluating an RSV vaccine. Eligible participants will receive study-related care and medication at no cost.
In the News:
Submit to learn more:
Please note: You may or may not benefit medically from taking part and you are able to opt out at anytime and do not have to give us a reason for doing so. Your primary care physician will be informed about your participation and all medical assessments that will be carried out as part of the study. If during screening any abnormal results are found your primary care physician will also be informed.